Literature DB >> 9681589

Altered adhesion efficiency and fibronectin content in fibroblasts from schizophrenic patients.

Y Miyamae1, Y Nakamura, Y Kashiwagi, T Tanaka, T Kudo, M Takeda.   

Abstract

Cultured fibroblasts from the cutaneous tissue of 16 schizophrenic patients were compared with 16 control cultured fibroblasts from the healthy subjects. The fibroblasts from the schizophrenic patients showed a decreased adhesion efficiency within 30 min after plating compared to that of the control subjects. However, after 90 min, there was no significant difference between the groups, where more than 90% of the cells from both groups had adhesed to the plate. By immunohistochemistry and western blotting using the antibodies against integrin (VLA5), talin, vinculin, fodrin, vimentin, ankyrin, plectin, fibronectin, and focal adhesion kinase (FAK), there was no significant difference in localization and amount between the groups. The amount of fibronectin released into the medium in which the fibroblast had already kept confluency showed no significant difference between the groups. However, the fibronectin content in cell lysate within 48 h after plating was significantly lower in the schizophrenic group.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681589     DOI: 10.1046/j.1440-1819.1998.00386.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  5 in total

Review 1.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

2.  Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.

Authors:  Michael Maes; Sunee Sirivichayakul; Buranee Kanchanatawan; Aristo Vodjani
Journal:  Neurotox Res       Date:  2019-05-10       Impact factor: 3.911

3.  Transcriptomic and Proteomic Analysis of CRISPR/Cas9-Mediated ARC-Knockout HEK293 Cells.

Authors:  Yu-Yuan Wang; Shih-Hsin Hsu; Hsin-Yao Tsai; Fu-Yu Cheng; Min-Chih Cheng
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

4.  Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target.

Authors:  Daniela Rodrigues-Amorim; Tania Rivera-Baltanás; Patricia Fernández-Palleiro; Marta Iglesias-Martínez-Almeida; Luis Freiría-Martínez; Cynthia Jarmardo-Rodriguez; María Del Carmen Vallejo-Curto; María Álvarez-Ariza; Marta López-García; Elena de Las Heras; Alejandro García-Caballero; José Manuel Olivares; Carlos Spuch
Journal:  Cell Mol Neurobiol       Date:  2021-03-12       Impact factor: 5.046

5.  Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative?

Authors:  Nicholas A Matigian; Richard D McCurdy; François Féron; Christopher Perry; Heather Smith; Cheryl Filippich; Duncan McLean; John McGrath; Alan Mackay-Sim; Bryan Mowry; Nicholas K Hayward
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.